The magnitude of the spike-binding antibody response was significantly correlated with RBD-binding, hemagglutination, and the ACE2-blocking antibody response in patients with COVID-19 (see Fig. S1 in the supplemental material), indicating the protective potential of anti-spike antibodies elicited upon natural infection. Here, ACE2 is linked to COVID-19.